|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 294.55 USD | +1.45% |
|
+17.68% | +59.47% |
| 18/07 | Nomura Adjusts BeOne Medicines Price Target to $352.60 From $347.02, Maintains Buy Rating | MT |
| 18/07 | Nomura Adjusts BeOne Medicines' Price Target to HK$209.92 From HK$206.60, Keeps at Buy | MT |
EPS & Dividend: BeOne Medicines Ltd.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -19.13 | -15.23 | -19.43 | -8.45 | -6.12 | 1.574 | 6.64 | 10.11 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 258.39 | 270.93 | 219.94 | 180.36 | 184.71 | 294.55 | 294.55 | 294.55 |
| Nbr of stocks (in thousands) | 90,924 | 102,770 | 103,859 | 104,578 | 106,476 | 118,650 | - | - |
| Announcement Date | 25/2/21 | 25/2/22 | 27/2/23 | 26/2/24 | 27/2/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: BeOne Medicines Ltd.
More events
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | 187.15x | 8.68x | 6.41x | ||
| 0.87% | 0.99% | 39.36x | 4.09x | 5.74x | ||
| 0.4% | 0.37% | 46.97x | 2.25x | 9.52x | ||
| -.--% | -.--% | 21.47x | 4.2x | 2.51x | ||
| 1.08% | 1.2% | 24.43x | 2.14x | 1.98x | ||
| -.--% | -.--% | 15.36x | 1.15x | 1.76x | ||
| -.--% | -.--% | -40.18x | 40.93x | 8.92x | ||
| 0.31% | 0.33% | 25.53x | 2.82x | 5.26x | ||
| -.--% | -.--% | -41.26x | -56.89x | 14.54x | ||
| -.--% | -.--% | 24.48x | 10.67x | 3.91x | ||
| Average | 0.26% | 0.29% | 30.33x | 2.00x | 6.06x | |
| Weighted average by Cap. | 0.35% | 0.39% | 51.35x | 3.41x | 5.99x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition